AU1587392A - The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d) - Google Patents

The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)

Info

Publication number
AU1587392A
AU1587392A AU15873/92A AU1587392A AU1587392A AU 1587392 A AU1587392 A AU 1587392A AU 15873/92 A AU15873/92 A AU 15873/92A AU 1587392 A AU1587392 A AU 1587392A AU 1587392 A AU1587392 A AU 1587392A
Authority
AU
Australia
Prior art keywords
diarrheal
ibs
phase
treatment
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15873/92A
Inventor
George Gilbert Cloyd
Allison Barretto Felarca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Eaton Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharmaceuticals Inc filed Critical Norwich Eaton Pharmaceuticals Inc
Publication of AU1587392A publication Critical patent/AU1587392A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
AU15873/92A 1991-03-15 1992-01-31 The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d) Abandoned AU1587392A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66978691A 1991-03-15 1991-03-15
US669786 1991-03-15

Publications (1)

Publication Number Publication Date
AU1587392A true AU1587392A (en) 1992-10-21

Family

ID=24687738

Family Applications (2)

Application Number Title Priority Date Filing Date
AU15873/92A Abandoned AU1587392A (en) 1991-03-15 1992-01-31 The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
AU15770/92A Abandoned AU1577092A (en) 1991-03-15 1992-03-05 The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU15770/92A Abandoned AU1577092A (en) 1991-03-15 1992-03-05 The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)

Country Status (2)

Country Link
AU (2) AU1587392A (en)
WO (2) WO1992016214A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI98343C (en) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Oral formulation
DE19732903A1 (en) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet formulation for the treatment of the intestinal tract
ATE269710T1 (en) * 1997-09-26 2004-07-15 Medeva Europ Ltd PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
IT1301947B1 (en) * 1998-07-28 2000-07-20 Chiesi Farma Spa PHARMACEUTICAL FORMULATIONS OF BECLOMETASONE DEPROPIONED FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES OF THE MUCOSA
US6962717B1 (en) 1999-01-29 2005-11-08 Disphar International B.V. Pharmaceutical compositions
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
CN1173695C (en) 1999-06-14 2004-11-03 科斯默股份公司 Controlled release and taste masking oral pharmaceutical compositions
AU2005209948B2 (en) * 2004-02-06 2009-09-10 Pharmatel (R&D) Pty Limited Use of aminosalicylates in diarrhoea-predominent Irritable Bowel Syndrome
US9149439B2 (en) 2005-03-21 2015-10-06 Sandoz Ag Multi-particulate, modified-release composition
JP2011500553A (en) * 2007-10-10 2011-01-06 ルピン・リミテッド Controlled release bioadhesive formulation targeting 5-colon of 5-aminosalicylic acid or its salts or metabolites
EA022886B1 (en) 2008-10-03 2016-03-31 Др. Фальк Фарма Гмбх Method of maintaining remission of ulcerative colitis in patients
WO2010072734A2 (en) * 2008-12-23 2010-07-01 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Targeting prodrugs and compositions for the treatment of gastrointestinal diseases
JP5768131B2 (en) 2010-09-10 2015-08-26 ファーマゼル ゲーエムベーハー Method for producing crystalline 5-aminosalicylic acid
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US20130316000A1 (en) * 2012-05-19 2013-11-28 Enoch Bortey Compositions and methods for treatment of irritable bowel syndrome with 5-aminosalicylate
WO2015193788A1 (en) * 2014-06-16 2015-12-23 Valpharma International S.P.A. Formulation for oral administration containing mesalazine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211777A (en) * 1977-11-25 1980-07-08 Fisons Limited Compositions comprising a compound having sodium cromoglycate activity and aminosalicylic acid
JPS57500432A (en) * 1980-03-20 1982-03-11
SE8003805L (en) * 1980-05-21 1981-11-22 Haessle Ab A PHARMACEUTICAL PREPARATION WITH IMPROVED EMISSION PROPERTY
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
US4657900A (en) * 1983-09-27 1987-04-14 Rowell Laboratories Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method
US5010069A (en) * 1989-05-15 1991-04-23 Marion Laboratories, Inc. Stable liquid form of 5-aminosalicylic acid

Also Published As

Publication number Publication date
AU1577092A (en) 1992-10-21
WO1992016214A1 (en) 1992-10-01
WO1992016206A1 (en) 1992-10-01

Similar Documents

Publication Publication Date Title
AU1587392A (en) The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
AU2484692A (en) Cardiac arrest treatment
AU1138192A (en) Preparation of itaconic acid polymers
AU1041392A (en) Improvements in endoscopic clip appliers
IL109579A0 (en) Bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
AU1453488A (en) Novel compositions for therapeutic percutaneous embolization and the use thereof
AU2308692A (en) Water treatment system
AU1966992A (en) Skin treatment system
AU3590489A (en) Use of gamma-hydroxybutyric acid salts in the treatment of alcoholism and pharmaceutical compositions thereof
AU2722392A (en) Cooling water treatment composition
HU9401917D0 (en) Propionic acid derivatives
HU9202085D0 (en) Derivatives of 7-isoindolinyl-quinolone and of naphthyridone-carboxylic acid
AU2264892A (en) Magneto-hydrodynamic fluid treatment system
AU659456B2 (en) Fatty acid treatment
HK15392A (en) Sputtered titanium oxynitride films
AU2490492A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
AU2670992A (en) Waste-water treatment system
AU626005B1 (en) Treatment of endometriosis
AU7384094A (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
AU649546B2 (en) Dicarboxylic acid derivatives and process for preparation thereof
AU4225989A (en) Water treatment system
AU1028892A (en) Phenoxyalkylcarboxylic acid derivatives and process of preparing the same
ZA929738B (en) New use of amino acid derivatives.
ZA932576B (en) 1,2,4-benzothiadiazine-3-carboxylic acid derivatives, their preparation and their use
AU5773794A (en) 4-amino-3-hydroxycarboxylic acid and their use as anitvirals